Related to Life Technologies Partners with SATuRN to Increase Access to HIV Testing in Africa

• U87MG Glioblastoma Cell Line Sequenced in Under a Month
  
• Asuragen Allies with Clinical Centers to Validate miRNA Pancreatic Cancer Test
  
• Scientists Solve 3-D Crystal Structure of Retroviral Integrase Bound to Viral DNA
  
• Oxford Nanopore Secures About $27.73M to Progress Nanopore-Based Label-Free Sequencing Platform
  
• Agilent Sells In Vitro Diagnostic Segment Hycor to Linden
  
• Optimer Reports Positive Phase III Data for Antibiotic against C. Difficile
  
• Zetiq Reports Clinical Validation of Platform for Bladder Cancer Diagnosis
  
• Nanotech-Based DNA Sequencer that Distinguishes between the Four Bases Developed
  
• LFB Licenses Thallion’s Early-Stage Candidate for Treating STEC Infections
  
• BG Medicine Forges Pact with Merck & Co. to Develop a Molecular Diagnostic for Lipid Disorders
  
• NABsys Pockets $7M to Progress Solid-State DNA Sequencing Platform
  
• Scientists Use shRNA to Remove Key HIV Co-Receptor
  
• Abbott to Use BG Medicine’s Heart-Failure Biomarker in Point-of-Care Test
  
• Institute for Systems Biology Uses Complete Genomics’ Sequencing Service to Validate Miller Syndrome Gene
  
• Takara Bio Taps University of Pennsylvania to Help Advance HIV Gene Therapy into U.S. Clinical Investigations
  
• Ambry to Offer Sequence-Enrichment Capabilities with RainDance’s RDT1000 Platform
  
• Bar Harbor BioTechnology Gains PCR and Real-Time PCR Patents from Life Technologies
  
• Existing HIV Therapies Also Block Virus Associated with Prostate Cancer and Chronic Fatigue Syndrome
  
• Analysis of HIV-1 Clade C Protein Structural Complex Finds HIV Antibody Is Autoreactive to CD4
  
• Scientists Elucidate How an HIV Protein Neutralizes an Inhibiting Host Factor